168 related articles for article (PubMed ID: 11467757)
1. Evidence for maximal treatment of atherosclerosis: drastic reduction of cholesterol and fibrinogen restores vascular homeostasis.
Jaeger BR
Ther Apher; 2001 Jun; 5(3):207-11. PubMed ID: 11467757
[TBL] [Abstract][Full Text] [Related]
2. Changes in myocardial vasoreactivity after drastic reduction of plasma fibrinogen and cholesterol: a clinical study in long-term heart transplant survivors using positron emission tomography.
Jaeger BR; Bengel FM; Odaka K; Uberfuhr P; Labarrere CA; Bengsch S; Engelschalk C; Kreuzer E; Reichart B; Schwaiger M; Seidel D
J Heart Lung Transplant; 2005 Dec; 24(12):2022-30. PubMed ID: 16364844
[TBL] [Abstract][Full Text] [Related]
3. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
[TBL] [Abstract][Full Text] [Related]
4. Long-term prevention of premature coronary atherosclerosis in homozygous familial hypercholesterolemia.
Jaeger BR; Tsobanelis T; Bengel F; Schwaiger M; Seidel D
J Pediatr; 2002 Jul; 141(1):125-8. PubMed ID: 12091863
[TBL] [Abstract][Full Text] [Related]
5. Heparin-Induced extracorporeal low-density lipoprotein precipitation apheresis: a new therapeutic concept in the treatment of sudden hearing loss.
Suckfüll M
Ther Apher; 2001 Oct; 5(5):377-83. PubMed ID: 11778923
[TBL] [Abstract][Full Text] [Related]
6. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy].
Seidel D
Z Kardiol; 2003; 92(Suppl 3):III6-27. PubMed ID: 14663597
[TBL] [Abstract][Full Text] [Related]
7. Heparin-mediated extracorporeal LDL/fibrinogen precipitation--H.E.L.P.--in coronary and cerebral ischemia.
Jaeger BR; Marx P; Pfefferkorn T; Hamann G; Seidel D
Acta Neurochir Suppl; 1999; 73():81-4. PubMed ID: 10494346
[TBL] [Abstract][Full Text] [Related]
8. [Heparin-induced extracorporeal LDL precipitation (HELP) in therapy refractory hypercholesterolemia and coronary heart disease: effect on clinical and morphological regression of coronary sclerosis].
Schuff-Werner P
Z Kardiol; 1997; 86 Suppl 1():57-64. PubMed ID: 9173722
[TBL] [Abstract][Full Text] [Related]
9. [Heparin-induced extracorporeal LDL precipitation (H.E.L.P.)].
Horstkotte D; Mellwig KP
Z Kardiol; 2003; 92(Suppl 3):III1-5. PubMed ID: 14663596
[TBL] [Abstract][Full Text] [Related]
10. [Hypercholesteremia and hyperfibrinogenemia in sudden deafness].
Suckfüll M; Thiery J; Wimmer C; Mees K; Schorn K
Laryngorhinootologie; 1997 Aug; 76(8):453-7. PubMed ID: 9376027
[TBL] [Abstract][Full Text] [Related]
11. [Clinical long-term results of H.E.L.P.-apheresis].
Schuff-Werner P
Z Kardiol; 2003; 92(Suppl 3):III28-9. PubMed ID: 14663598
[TBL] [Abstract][Full Text] [Related]
12. [H.E.L.P. therapy (heparin-induced extracorporeal LDL precipitation) in sudden deafness].
Walch C; Anderhuber W; Walzl M
Laryngorhinootologie; 1996 Nov; 75(11):641-5. PubMed ID: 9063830
[TBL] [Abstract][Full Text] [Related]
13. LDL-apheresis accelerates the recovery of nonarteritic acute anterior ischemic optic neuropathy.
Ramunni A; Giancipoli G; Guerriero S; Lapenna L; Saracino A; Saliani MT; Capurso A; Sborgia C; Coratelli P
Ther Apher Dial; 2005 Feb; 9(1):53-8. PubMed ID: 15828907
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of sudden hearing loss through Fibrinogen/LDL-apheresis. A prospective, randomized multicenter trial].
Suckfüll M; Seidel D; Thiery J; Mazurek B; Jaehne M; Gronemeyer J; Reichel O; Sasama J; Kichigina S; Möller M; Beil FU; Schrameyer-Wernecke A; Kassner U; Koch M; Jaeger B; Osterkorn K; Osterkorn D
Z Kardiol; 2003; 92(Suppl 3):III59-63. PubMed ID: 14663604
[TBL] [Abstract][Full Text] [Related]
15. [Heparin-induced extracorporeal LDL precipitation (H.E.L.P.). A new therapeutic possibility in vascular occlusion of the retina--initial results].
Haas A; Walzl M; Faulborn J; Walzl B; Berglöff J; Eckhardt M
Ophthalmologe; 1994 Jun; 91(3):283-7. PubMed ID: 8086743
[TBL] [Abstract][Full Text] [Related]
16. Increased cerebral CO(2) reactivity after heparin-mediated extracorporal LDL precipitation (HELP) in patients with coronary heart disease and hyperlipidemia.
Pfefferkorn TK; Knüppel HP; Jaeger BR; Thiery J; Hamann GF
Stroke; 1999 Sep; 30(9):1802-6. PubMed ID: 10471427
[TBL] [Abstract][Full Text] [Related]
17. [Heparin-induced extacorporeal low-density lipoprotein-lipoprotein alpha-fibrinogen precipitation in 36 cases].
Mo JK; Li YX; Lei D; Wu DH
Di Yi Jun Yi Da Xue Xue Bao; 2002 Mar; 22(3):278-9. PubMed ID: 12390791
[TBL] [Abstract][Full Text] [Related]
18. [Effects of LDL-apheresis--more than reduction of cholesterol?].
Schettler V; Wieland E
Dtsch Med Wochenschr; 2007 Mar; 132(11):575-8. PubMed ID: 17342636
[TBL] [Abstract][Full Text] [Related]
19. Role of low-density lipoprotein apheresis.
Ziajka P
Am J Cardiol; 2005 Aug; 96(4A):67E-69E. PubMed ID: 16098847
[TBL] [Abstract][Full Text] [Related]
20. Heparin-mediated extracorporeal low-density lipoprotein precipitation: rationale for a specific adjuvant therapy in cardiovascular disease.
Blessing F; Wang Y; Walli AK; Seidel D
Transfus Apher Sci; 2004 Jun; 30(3):255-66. PubMed ID: 15172631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
